Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Lipoprotein(a)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Active Not RecruitingNCT06372925
What this trial is testing

Intravascular Imaging Study of the Effect of Inclisiran on Plaque in Patients With Acute Myocardial Infarction

Who this might be right for
Plaque, Atherosclerotic
Novartis Pharmaceuticals 318
Large-scale testing (Phase 3)Study completedNCT00092625
What this trial is testing

Co-administration Study in Patients With Elevated Cholesterol and Coronary Heart Disease (0653-803)

Who this might be right for
HypercholesterolemiaCoronary Disease
Organon and Co 442
Not applicableStudy completedNCT06163443
What this trial is testing

Evaluating the Impact of B Vitamin Supplementation (Soloways™) on Homocysteine and LDL-C Levels in Patients With MTHFR, MTR, and MTRR Polymorphisms.

Who this might be right for
HyperhomocysteinemiaHyperlipoproteinemias
S.LAB (SOLOWAYS) 54
Large-scale testing (Phase 3)Study completedNCT02326220
What this trial is testing

Study of Alirocumab (REGN727/SAR236553) in Patients With Heterozygous Familial Hypercholesterolemia (HeFH) Undergoing Low-density Lipoprotein (LDL) Apheresis Therapy

Who this might be right for
Heterozygous Familial Hypercholesterolemia
Regeneron Pharmaceuticals 62
Large-scale testing (Phase 3)Study completedNCT02189837
What this trial is testing

Effects on Lipoprotein Metabolism From PCSK9 Inhibition Utilizing a Monoclonal Antibody

Who this might be right for
Primary Hyperlipidemia and Mixed Dyslipidemia
Amgen 89
Not applicableEnded earlyNCT01447901
What this trial is testing

Duration of Effect of Alipogene Tiparvovec Treatment, Which Was Administered in Other Studies

Who this might be right for
Hyperlipoproteinemia Type I
Amsterdam Molecular Therapeutics 19
Post-approval studies (Phase 4)UnknownNCT02077257
What this trial is testing

LDL-C Lowering Efficacy and Safety of Rosuvastatin 20 mg/Day to10 mg/Day in Chinese ACS(Acute Coronary Syndrome) Patients

Who this might be right for
Acute Coronary Syndrome
Committee of Cardio-Cerebral-Vascular Diseases of GSC 1,060
Testing effectiveness (Phase 2)Looking for participantsNCT07614984
What this trial is testing

A Clinical Trial of MK-7262 and Enlicitide in Participants With High Lipoprotein(a) (MK-7262-004)

Who this might be right for
Lipoprotein(a)
Merck Sharp & Dohme LLC 750
Post-approval studies (Phase 4)Study completedNCT00747149
What this trial is testing

A Diabetes Study to Treat A Population Previously Not at Target

Who this might be right for
Type 2 Diabetes
AstraZeneca 598
Testing effectiveness (Phase 2)Looking for participantsNCT07368608
What this trial is testing

BEBT-701 in Patients With Mild to Moderate Hypertension and Elevated Low-Density Lipoprotein Cholesterol（LDL-C）

Who this might be right for
Mild to Moderate Hypertension and Elevated Low-Density Lipoprotein Cholesterol
BeBetter Med Inc 340
Not applicableNot Yet RecruitingNCT07157878
What this trial is testing

Gingival Crevicular Fluid Oxidized Low-Density Lipoprotein Levels in Health and Stage III/IV Periodontitis

Who this might be right for
Periodontal DiseasesLDL Hyperlipoproteinemia
shaimaa hamdy 40
Large-scale testing (Phase 3)Study completedNCT05687071
What this trial is testing

A Long-term Trial of ETC-1002 in Patients With Hyper-LDL Cholesterolemia

Who this might be right for
Hyper-low-density Lipoprotein (LDL) Cholesterolemia
Otsuka Pharmaceutical Co., Ltd. 130
Large-scale testing (Phase 3)Looking for participantsNCT06813911
What this trial is testing

Lp(a) Lowering Study of Pelacarsen (TQJ230) With Background Inclisiran in Participants With Elevated Lp(a) and Established ASCVD

Who this might be right for
Atherosclerotic Cardiovascular Disease (ASCVD)
Novartis Pharmaceuticals 340
Not applicableUnknownNCT05135234
What this trial is testing

Developing a Physiological Understanding of High Duration Activity

Who this might be right for
Sedentary LifestyleHyperinsulinemiaGlucose Tolerance Impaired+5 more
University of Houston 60
Large-scale testing (Phase 3)Study completedNCT00654446
What this trial is testing

IIIb 6 Week Open Label Multicentre Rosuvastatin & Simvastatin

Who this might be right for
Fredrickson Type IIa & Type IIb Dyslipidaemia
AstraZeneca 442
Testing effectiveness (Phase 2)Looking for participantsNCT06496243
What this trial is testing

Impact of Obicetrapib and Obicetrapib Plus Repatha on Lp(a) Levels

Who this might be right for
Dyslipidemias
NewAmsterdam Pharma 69
Not applicableStudy completedNCT06595069
What this trial is testing

A Real-world Study to Assess the Characteristics and Long-term Effectiveness of Inclisiran in Chinese Adult Patients

Who this might be right for
Hypercholesterolemia
Novartis 600
Not applicableStudy completedNCT02769741
What this trial is testing

A Controlled-Feeding Study to Assess the Effect of Cashews on Fasting Lipoprotein Levels

Who this might be right for
Healthy Volunteers
Kraft Heinz Company 51
Large-scale testing (Phase 3)Study completedNCT00653744
What this trial is testing

Rosuvastatin Versus Atorvastatin in the Treatment of Hypercholesterolaemia in African American Subjects(ARIES)

Who this might be right for
HypercholesterolemiaDyslipidaemia
AstraZeneca 1,700
Not applicableStudy completedNCT05378529
What this trial is testing

A Cross-sectional Study of Lipoprotein(a) Levels in Patients With Documented History of Atherosclerotic Cardiovascular Disease (ASCVD)

Who this might be right for
Atherosclerotic Cardiovascular Disease
Amgen 39,480
Next Page